June 18, 2023
2 min watch
Save
VIDEO: Reimbursement available for Iheezo ocular anesthetic
Key takeaways:
- Iheezo is an FDA-approved ocular anesthetic.
- It is reimbursable by Medicare and commercial insurance.
SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, William F. Wiley, MD, speaks about Iheezo, the first ocular anesthetic approved by the FDA in nearly 14 years.
“It has been a great addition to our protocol for cataract surgery, but it can also be used for any ocular surgery,” he said.
Iheezo (chloroprocaine hydrochloride ophthalmic gel 3%, Harrow) has a permanent J-code that will enable reimbursement by Medicare and many commercial insurances.
In the clinical trials, no patient administered Iheezo needed supplemental anesthesia to complete the procedure.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Wiley reports consulting for Harrow.
Read more about